Alvotech SA
Follow $ALVO
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ALVO by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredsnapshot unavailable for ALVO. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ALVO moving today?
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ALVO overview
Related filings and maps
Congress activity in ALVO
No receipt-qualified Congressional disclosure is present for ALVO in the cached public ledger.
ALVO contract awards, year to date.
Public federal awards linked to this ticker.
ALVO lobbying filings, year to date.
Registered lobbying filings matched to Alvotech SA.